Heart Failure: A Palliative Medicine Review of Disease, Therapies, and Medications With a Focus on Symptoms, Function, and Quality of Life.

J Pain Symptom Manage

Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada; Division of Palliative Care, Department of Supportive Care, University Health Network, Toronto, Ontario, Canada; Division of Palliative Care, Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address:

Published: May 2020

Despite significant advances in heart failure (HF) treatment, HF remains a progressive, extremely symptomatic, and terminal disease with a median survival of 2.1 years after diagnosis. HF often leads to a constellation of symptoms, including dyspnea, fatigue, depression, anxiety, insomnia, pain, and worsened cognitive function. Palliative care is an approach that improves the quality of life of patients and their caregivers facing the problems associated with life-threatening illness and therefore is well suited to support these patients. However, historically, palliative care has often focused on supporting patients with malignant disease, rather than a progressive chronic disease such as HF. Predicting mortality in patients with HF is challenging. The lack of obvious transition points in disease progression also raises challenges to primary care providers and specialists to know at what point to integrate palliative care during a patient's disease trajectory. Although therapies for HF often result in functional and symptomatic improvements including health-related quality of life (HRQL), some patients with HF do not demonstrate these benefits, including those patients with a preserved ejection fraction. Provision of palliative care for patients with HF requires an understanding of HF pathogenesis and common medications used for these patients, as well as an approach to balancing life-prolonging and HRQL care strategies. This review describes HF and current targeted therapies and their effects on symptoms, hospital admission rates, exercise performance, HRQL, and survival. Pharmacological interactions with and precautions related to commonly used palliative care medications are reviewed. The goal of this review is to equip palliative care clinicians with information to make evidence-based decisions while managing the balance between optimal disease management and patient quality of life.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2019.12.357DOI Listing

Publication Analysis

Top Keywords

palliative care
24
quality life
16
heart failure
8
care
8
patients
8
palliative
7
disease
7
failure palliative
4
palliative medicine
4
medicine review
4

Similar Publications

Unlabelled: The number of individuals with advanced cancer is increasing, making palliative care more important. However, there is limited knowledge in the Netherlands about the quality of care received by patients in the palliative phase. This is why the Netherlands comprehensive cancer organization (IKNL) started the 'eQuiPe study' to understand the experienced quality of care and quality of life of patients with advanced cancer and their relatives to further improve palliative care.

View Article and Find Full Text PDF

Recommendations for Specialty Palliative APRN Graduate Education.

Nurse Educ

November 2024

Author Affiliations: Palliative Care Catalyst Network (Ms Dahlin), Beverly, Massachusetts, Palliative Care Services (Ms Dahlin), Mass General Brigham-Salem Hospital, Salem, Massachusetts; Meyers College of Nursing (Dr Wholihan), New York University, New York, New York; School of Nursing (Dr Wiencek), Loyola University, New Orleans, Louisiana; College of Nursing (Dr Acker), University of Alabama Capstone, Tuscaloosa, Alabama; College of Nursing (Dr Breakwell), Marquette University, Milwaukee, Wisconsin; School of Nursing (Ms Buschman), Columbia University, New York, New York; College of Nursing (Dr Cormack), Medical University of South Carolina, Charleston, South Carolina; College of Nursing (Dr DeSanto-Madaya), University of Rhode Island, Providence, Rhode Island; School of Nursing (Dr Doherty), University of Pennsylvania, Philadelphia, Pennsylvania; School of Nursing (Dr Edwards), The University of Alabama at Birmingham, Birmingham, Alabama; School of Nursing (Dr English), University of Colorado Anschutz Medical Campus, Aurora, Colorado; School of Medicine and College of Nursing (Dr Fink), University of Colorado Anschutz Medical Campus, Aurora, Colorado; Interprofessional MSPC & Palliative Certificate Programs (Dr Goodnough), University of Colorado Anschutz Medical Campus, Aurora, Colorado; College of Nursing (Dr Lindell), Medical University of South Carolina, Charleston, South Carolina; Francis Payne Bolton School of Nursing (Dr Mazanec), Case Western Reserve University, Cleveland, Ohio; College of Nursing (Dr McHugh), Columbia University Irving Medical Center, New York, New York; School of Nursing (Dr Moore), University of Southern Alabama, Mobile, Alabama; College of Nursing (Dr Obrecht), University of Illinois Chicago, Chicago, Illinois; School of Nursing (Dr Pawlow), University of Pennsylvania, Philadelphia, Pennsylvania; Palliative Care Department (Dr Johnstone-Petty), Providence Alaska Medical Group, Anchorage, Alaska; College of Nursing (Dr Quinlin), The Ohio State University, Columbus, Ohio; and School of Nursing (Dr Tresgallo), Columbia University Irving Medical Center, New York, New York.

Background: Advanced practice registered nurses (APRNs) are essential to care for the growing number of individuals with advanced illness given the shortage of palliative care clinicians.

Problem: Graduate education for specialty practice palliative APRNs lacks consistency in structure, content, and standardization of specialty palliative APRN education.

Approach: A workgroup of expert palliative APRNs and graduate faculty conducted focused discussions and a literature review to develop consensus recommendations based on national palliative APRN competencies and aligned with the 8 core concepts of the AACN Essentials.

View Article and Find Full Text PDF

Background: The delivery of cancer services changed significantly during the COVID-19 pandemic. This study aimed to describe changes in presentations, assess the change in recommendations by the MDT during the pandemic, and describe the subsequent long-term impact of these changes on survival rates in patients with EG cancer.

Methods: A retrospective cohort study was designed comparing three patient groups of those referred to EG MDT in the same 6-month period pre-pandemic (PP;2019) during the initial phase of the pandemic (P1;2020) and the year after the initial phase (P2;2021).

View Article and Find Full Text PDF

Background: People with intellectual disabilities are less likely to have access to palliative care, and the evidence shows that their deaths are often unanticipated, unplanned for, and poorly managed. Within the general population, people from minoritised ethnic groups are under-represented within palliative care services. End-of-life care planning with people with intellectual disabilities from minoritised ethnic groups may be a way to address these issues.

View Article and Find Full Text PDF

Introduction: Physical Activity (PA) and its links to frailty, quality of life (QoL), and other comorbidities in older Ugandans living with HIV remain under-explored.

Methods: We analyzed data from three annual assessments of older people living with HIV (PLWH) and age- and sex-similar people not living with HIV (PnLWH). We fitted linear generalized estimating equations (GEE) regression models to estimate the correlates of PA, including demographics, frailty, QoL, HIV, and other comorbidities.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!